Literature DB >> 19696776

Risk factors: Lipoprotein(a) and coronary disease-moving closer to causality.

John Danesh, Sebhat Erqou.   

Abstract

Mesh:

Substances:

Year:  2009        PMID: 19696776     DOI: 10.1038/nrcardio.2009.138

Source DB:  PubMed          Journal:  Nat Rev Cardiol        ISSN: 1759-5002            Impact factor:   32.419


× No keyword cloud information.
  10 in total

1.  A NEW SERUM TYPE SYSTEM IN MAN--THE LP SYSTEM.

Authors:  K BERG
Journal:  Acta Pathol Microbiol Scand       Date:  1963

Review 2.  Lipoprotein(a): a unique risk factor for cardiovascular disease.

Authors:  Erdembileg Anuurad; Michael B Boffa; Marlys L Koschinsky; Lars Berglund
Journal:  Clin Lab Med       Date:  2006-12       Impact factor: 1.935

3.  Genome-wide haplotype association study identifies the SLC22A3-LPAL2-LPA gene cluster as a risk locus for coronary artery disease.

Authors:  David-Alexandre Trégouët; Inke R König; Jeanette Erdmann; Alexandru Munteanu; Peter S Braund; Alistair S Hall; Anika Grosshennig; Patrick Linsel-Nitschke; Claire Perret; Maylis DeSuremain; Thomas Meitinger; Ben J Wright; Michael Preuss; Anthony J Balmforth; Stephen G Ball; Christa Meisinger; Cécile Germain; Alun Evans; Dominique Arveiler; Gérald Luc; Jean-Bernard Ruidavets; Caroline Morrison; Pim van der Harst; Stefan Schreiber; Katharina Neureuther; Arne Schäfer; Peter Bugert; Nour E El Mokhtari; Jürgen Schrezenmeir; Klaus Stark; Diana Rubin; H-Erich Wichmann; Christian Hengstenberg; Willem Ouwehand; Andreas Ziegler; Laurence Tiret; John R Thompson; Francois Cambien; Heribert Schunkert; Nilesh J Samani
Journal:  Nat Genet       Date:  2009-02-08       Impact factor: 38.330

4.  Fibrinogen and coronary heart disease: test of causality by 'Mendelian randomization'.

Authors:  Bernard Keavney; John Danesh; Sarah Parish; Alison Palmer; Sarah Clark; Linda Youngman; Marc Delépine; Mark Lathrop; Richard Peto; Rory Collins
Journal:  Int J Epidemiol       Date:  2006-07-26       Impact factor: 7.196

5.  Has lipoprotein 'little' (a) shrunk?

Authors:  E S Barnathan
Journal:  JAMA       Date:  1993-11-10       Impact factor: 56.272

Review 6.  Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality.

Authors:  Sebhat Erqou; Stephen Kaptoge; Philip L Perry; Emanuele Di Angelantonio; Alexander Thompson; Ian R White; Santica M Marcovina; Rory Collins; Simon G Thompson; John Danesh
Journal:  JAMA       Date:  2009-07-22       Impact factor: 56.272

7.  Report of the National Heart, Lung, and Blood Institute Workshop on Lipoprotein(a) and Cardiovascular Disease: recent advances and future directions.

Authors:  Santica M Marcovina; Marlys L Koschinsky; John J Albers; Sonia Skarlatos
Journal:  Clin Chem       Date:  2003-11       Impact factor: 8.327

8.  Lipoprotein(a) levels and risk of future coronary heart disease: large-scale prospective data.

Authors:  Anna Bennet; Emanuele Di Angelantonio; Sebhat Erqou; Gudny Eiriksdottir; Gunnar Sigurdsson; Mark Woodward; Ann Rumley; Gordon D O Lowe; John Danesh; Vilmundur Gudnason
Journal:  Arch Intern Med       Date:  2008-03-24

9.  Genetically elevated lipoprotein(a) and increased risk of myocardial infarction.

Authors:  Pia R Kamstrup; Anne Tybjaerg-Hansen; Rolf Steffensen; Børge G Nordestgaard
Journal:  JAMA       Date:  2009-06-10       Impact factor: 56.272

Review 10.  New insights into the role of lipoprotein(a)-associated lipoprotein-associated phospholipase A2 in atherosclerosis and cardiovascular disease.

Authors:  Sotirios Tsimikas; Loukas D Tsironis; Alexandros D Tselepis
Journal:  Arterioscler Thromb Vasc Biol       Date:  2007-07-12       Impact factor: 8.311

  10 in total
  3 in total

Review 1.  Emerging genomic applications in coronary artery disease.

Authors:  Samir B Damani; Eric J Topol
Journal:  JACC Cardiovasc Interv       Date:  2011-05       Impact factor: 11.195

2.  Higher Lipoprotein (a) Levels Are Associated with Better Pulmonary Function in Community-Dwelling Older People - Data from the Berlin Aging Study II.

Authors:  Nikolaus Buchmann; Ursula Kassner; Kristina Norman; David Goldeck; Rahel Eckardt; Graham Pawelec; Elisabeth Steinhagen-Thiessen; Ilja Demuth
Journal:  PLoS One       Date:  2015-09-30       Impact factor: 3.240

Review 3.  Lipoprotein(a): a promising marker for residual cardiovascular risk assessment.

Authors:  Anping Cai; Liwen Li; Ying Zhang; Yujin Mo; Weiyi Mai; Yingling Zhou
Journal:  Dis Markers       Date:  2013-10-22       Impact factor: 3.434

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.